News - Vivus, Astellas Pharma

Filter

Current filters:

VivusAstellas Pharma

Popular Filters

Astellas files for EU approval of EC905, EMA accepts avanafil filing

28-03-2012

The European subsidiary of Japanese drug major Astellas Pharma (Tokyo: 4503) has announced the submission…

Astellas PharmaavanafilEuropeMen's HealthPharmaceuticalRegulationVivus

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top